|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03737 ZHONGZHIPHARM
Nominal 
0.930 +0.030 (+3.333%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 101,503 | 284,574 | 178,379 | 93,179 |
| Net Cash from / (used in) Investing Activities | -- | (202,758) | 13,380 | (135,980) | (250,422) |
| Net Cash from / (used in) Financing Activities | -- | (154,618) | (68,144) | (40,831) | (71,933) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (255,873) | 229,810 | 1,568 | (229,176) |
| Cash & Cash Equivalents at beginning of period | -- | 381,010 | 153,381 | 151,032 | 380,333 |
| Effect of Foreign Exchange Rate Changes | -- | (769) | (2,181) | 781 | (125) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 124,368 | 381,010 | 153,381 | 151,032 |
| Remarks: | Real time quote last updated: 22/11/2024 14:35 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 83,440 |
| %Change | -38.147% |
| EPS / (LPS) | RMB 0.099 |
| NBV Per Share (¥) | RMB 1.282 |